MedTrace Logo

Comparing Relative Peripheral Refraction on Myopia Progression

NCT06758843 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2025-01-07

No results posted yet for this study

Summary

The investigators will test our hypothesis that parameters on peripheral defocus can regulate eye growth: For instance, the relative peripheral refraction measured by Multispectral Refraction Topography (MRT) would be significant different between two groups: fast speed and slow speed of axial length elongation (myopia progression) for 1 year with 2-3 follow-ups.

The goal of this observation study is to confirm the value of MRT in clinic. Could it predict myopia progression or not? By the parameters on relative peripheral refraction in children myopia, could include any of the following: both genders, 7\~17 years age groups, including healthy volunteers. The main question it aims to answer is:

Is any of relative peripheral refraction parameters measured by MRT could guide the clinics for predict myopia progression? Which parameters from MRT could predict the myopia fast progression at baseline ? There is a comparison between groups. Researchers will compare fast myopia progression group versus slow myopia progression group to see if any parameters differs at baseline.

Participants will be asked to the collection methods (such as spectacles, orhtokeratology, contact lens) and interventions; And each participant would be followed up for at least 2 times in one year to test the axial length and refractive error as well as parameters with MRT.

Conditions

  • Myopia

Interventions

OTHER

measure the axial length, visual acuity, and refraction at follow-up of 6- and 12-month

the intervention is follow-up with parameters to measure and data to record

Sponsors & Collaborators

  • Fuzhou Southeast Institute of Visual Ophthalmology

    lead OTHER

Eligibility

Min Age
7 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-23
Primary Completion
2024-12-29
Completion
2024-12-29

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06758843 on ClinicalTrials.gov